BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29463595)

  • 1. Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.
    Gulati T; Huang C; Caramia F; Raghu D; Paul PJ; Goode RJA; Keam SP; Williams SG; Haupt S; Kleifeld O; Schittenhelm RB; Gamell C; Haupt Y
    Mol Cell Proteomics; 2018 Jun; 17(6):1170-1183. PubMed ID: 29463595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E6AP promotes prostate cancer by reducing p27 expression.
    Raghu D; Paul PJ; Gulati T; Deb S; Khoo C; Russo A; Gallo E; Blandino G; Chan AL; Takano E; Sandhu SK; Fox SB; Williams S; Haupt S; Gamell C; Haupt Y
    Oncotarget; 2017 Jun; 8(26):42939-42948. PubMed ID: 28477016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP.
    Paul PJ; Raghu D; Chan AL; Gulati T; Lambeth L; Takano E; Herold MJ; Hagekyriakou J; Vessella RL; Fedele C; Shackleton M; Williams ED; Fox S; Williams S; Haupt S; Gamell C; Haupt Y
    Oncogene; 2016 Dec; 35(48):6235-6245. PubMed ID: 27641331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death.
    Birch SE; Kench JG; Takano E; Chan P; Chan AL; Chiam K; Veillard AS; Stricker P; Haupt S; Haupt Y; Horvath L; Fox SB
    Ann Oncol; 2014 Dec; 25(12):2392-2397. PubMed ID: 25231954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc.
    Kühnle S; Mothes B; Matentzoglu K; Scheffner M
    Proc Natl Acad Sci U S A; 2013 May; 110(22):8888-93. PubMed ID: 23671107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-LC based proteomic approach identifies that E6AP interacts with ENO1 and targets it for degradation in breast cancer cells.
    Mishra M; Sharma A; Thacker G; Trivedi AK
    IUBMB Life; 2019 Dec; 71(12):1896-1905. PubMed ID: 31329371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation.
    Kapoor I; Kanaujiya J; Kumar Y; Thota JR; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
    Oncotarget; 2016 Feb; 7(7):7640-56. PubMed ID: 26506232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.
    Zoubeidi A; Ettinger S; Beraldi E; Hadaschik B; Zardan A; Klomp LW; Nelson CC; Rennie PS; Gleave ME
    Mol Cancer Res; 2010 Jan; 8(1):119-30. PubMed ID: 20068069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer.
    Shiota M; Zoubeidi A; Kumano M; Beraldi E; Naito S; Nelson CC; Sorensen PH; Gleave ME
    Mol Cancer Res; 2011 Dec; 9(12):1755-66. PubMed ID: 21987172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.
    Talis AL; Huibregtse JM; Howley PM
    J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E6AP inhibits G-CSFR turnover and functions by promoting its ubiquitin-dependent proteasome degradation.
    Chhabra S; Kumar Y; Thacker G; Kapoor I; Lochab S; Sanyal S; Bhatt MLB; Chattopadhyay N; Trivedi AK
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1545-1553. PubMed ID: 28578910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
    Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
    J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.
    Liu X; Yuan H; Fu B; Disbrow GL; Apolinario T; Tomaic V; Kelley ML; Baker CC; Huibregtse J; Schlegel R
    J Biol Chem; 2005 Mar; 280(11):10807-16. PubMed ID: 15655249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6.
    Zheng L; Ding H; Lu Z; Li Y; Pan Y; Ning T; Ke Y
    Genes Cells; 2008 Mar; 13(3):285-94. PubMed ID: 18298802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.
    Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y
    Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer.
    Ma X; Zou L; Li X; Chen Z; Lin Q; Wu X
    Biomed Pharmacother; 2018 Mar; 99():445-450. PubMed ID: 29665645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activity.
    Chan AL; Grossman T; Zuckerman V; Campigli Di Giammartino D; Moshel O; Scheffner M; Monahan B; Pilling P; Jiang YH; Haupt S; Schueler-Furman O; Haupt Y
    Biochemistry; 2013 May; 52(18):3119-29. PubMed ID: 23581475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells.
    Zhou J; Chen X; Gilvary DL; Tejera MM; Eksioglu EA; Wei S; Djeu JY
    Sci Rep; 2015 Oct; 5():15085. PubMed ID: 26469759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells.
    Patterson SG; Wei S; Chen X; Sallman DA; Gilvary DL; Zhong B; Pow-Sang J; Yeatman T; Djeu JY
    Oncogene; 2006 Oct; 25(45):6113-22. PubMed ID: 16652143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.